Fusion Antibodies plc (LON:FAB – Get Free Report) insider Adrian Kinkaid acquired 120,000 shares of the business’s stock in a transaction dated Wednesday, September 4th. The shares were bought at an average price of GBX 3 ($0.04) per share, with a total value of £3,600 ($4,733.73).
Fusion Antibodies Price Performance
Shares of Fusion Antibodies stock opened at GBX 3.30 ($0.04) on Friday. Fusion Antibodies plc has a 12-month low of GBX 2.80 ($0.04) and a 12-month high of GBX 9.50 ($0.12). The firm has a market capitalization of £3.15 million, a PE ratio of -82.50 and a beta of 0.48. The company has a quick ratio of 2.36, a current ratio of 3.26 and a debt-to-equity ratio of 3.23. The stock’s fifty day moving average is GBX 3.21 and its 200-day moving average is GBX 3.52.
About Fusion Antibodies
Read More
- Five stocks we like better than Fusion Antibodies
- CD Calculator: Certificate of Deposit Calculator
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Fusion Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fusion Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.